ArticleCellular oncology (Dordrecht, Netherlands)2022

Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations.

Seul-Ki Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.